Article Details

Zhimeng Biopharma Announces Dosing of First Subject of Its Novel Antiepileptic Drug ... - AsiaOne

Retrieved on: 2022-05-12 08:15:23

Tags for this article:

Click the tags to see associated articles and topics

Zhimeng Biopharma Announces Dosing of First Subject of Its Novel Antiepileptic Drug ... - AsiaOne. View article details on hiswai:

Excerpt

SHANGHAI, May 12, 2022 /PRNewswire/ -- Shanghai Zhimeng Biopharma, Inc. ("Zhimeng"), announced dosing of the first participant in the US Phase I ...

Article found on: www.asiaone.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up